1.
Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study
by Liao, Fangzi
The American heart journal, 1998, Vol.136 (3), p.480-490
2.
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
by Oliver, M F
The Lancet (British edition), 1994, Vol.344 (8923), p.633-638
3.
Effects of Fluvastatin on Coronary Atherosclerosis in Patients With Mild to Moderate Cholesterol Elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])
by Herd, J.Alan
The American journal of cardiology, 1997, Vol.80 (3), p.278-286
4.
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
by Ericsson, C-G
The Lancet (British edition), 1996, Vol.347 (9005), p.849-853
5.
Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart Trial
by Ornish, D
The Lancet (British edition), 1990, Vol.336 (8708), p.129-133
6.
Effect of acute testosterone on myocardial ischemia in men with coronary artery disease
by Webb, Carolyn M
The American journal of cardiology, 1999, Vol.83 (3), p.437-439
7.
Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
by CLARKSON, T. B
The journal of clinical endocrinology and metabolism, 1998, Vol.83 (3), p.721-726
8.
Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women
by Barengolts, E I
Calcified tissue international, 1998, Vol.62 (3), p.209-213
9.
Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound
by Ge, J
Heart (British Cardiac Society), 1999, Vol.81 (6), p.621-627
10.
C-Reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes
by Abdelmouttaleb, Idrissia
The American heart journal, 1999, Vol.137 (2), p.346-351
11.
High Anti-Cytomegalovirus (CMV) IgG Antibody Titer is Associated With Coronary Artery Disease and May Predict Post-Coronary Balloon Angioplasty Restenosis
by Blum, Arnon
The American journal of cardiology, 1998, Vol.81 (7), p.866-868
12.
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis
by Thompson, G.R
The Lancet (British edition), 1995, Vol.345 (8953), p.811-816
13.
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis
by de Maat, Moniek P.M
The American journal of cardiology, 1999, Vol.83 (6), p.852-856
14.
Neovascularization in atherectomy specimens from patients with unstable angina: Implications for pathogenesis of unstable angina
by Tenaglia, Alan N
The American heart journal, 1998, Vol.135 (1), p.10-14
15.
The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus
by Epstein, SE
The Lancet (British edition), 1996, Vol.348, p.S13-S17
16.
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis
by Ye, S
British Heart Journal, 1995, Vol.73 (3), p.209-215
17.
In vivo validation of compensatory enlargement of atherosclerotic coronary arteries
by Hermiller, James B
The American journal of cardiology, 1993, Vol.71 (8), p.665-668
18.
Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide
by Suzuki, Jun-Ichi
Nature medicine, 1997, Vol.3 (8), p.900-903
19.
Stable versus unstable atherosclerosis: Clinical aspects
by Falk, Erling
The American heart journal, 1999, Vol.138 (5), p.S421-S425
20.
Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque
by Sabaté, Manel
The American journal of cardiology, 1999, Vol.84 (2), p.135-140
Filter electronic articles 5.860 Hits
Remove Filters
